Advertisement
Screener

Surgery Partners, Inc. (SGRY) Overview

Surgery Partners, Inc. (SGRY) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.12; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.28; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.18; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.02; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$10.92$12.79$14.98$17.55$20.56$24.092025-09-292026-09-29$10.92$15.59$22.25$31.77$45.37$64.772021-09-292026-09-29$4.45$7.72$13.42$23.32$40.52$70.402016-09-292026-09-29$4.45$7.72$13.42$23.32$40.52$70.402015-09-302026-09-29$4.45$7.72$13.42$23.32$40.52$70.402015-09-302026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$14.41
Previous close
$14.69
Change
-$0.28
Change (%)
-1.91%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

SGRY
-6.73%
S&P 500
(m)

1 year

SGRY
-34.23%
S&P 500
(m)

3 years

SGRY
-50.74%
S&P 500
(m)

5 years

SGRY
-65.97%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.12

-0.38-0.24-0.110.030.1631 Mar 2025: estimate (m); actual -0.3031 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.0230 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1830 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.2831 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1230 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.12(m)(m)
1 Jan 202631 Mar 2026(m)-0.28(m)(m)
1 Jul 202530 Sept 2025(m)-0.18(m)(m)
1 Apr 202530 Jun 2025(m)-0.02(m)(m)
1 Jan 202531 Mar 2025(m)-0.30(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.61

-1.41-1.04-0.66-0.280.0931 Dec 2021: estimate (m); actual -1.1231 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.5931 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.0931 Dec 2023(m)31 Dec 2024: estimate (m); actual -1.3331 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.6131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.61(m)(m)
1 Jan 202431 Dec 2024(m)-1.33(m)(m)
1 Jan 202331 Dec 2023(m)-0.09(m)(m)
1 Jan 202231 Dec 2022(m)-0.59(m)(m)
1 Jan 202131 Dec 2021(m)-1.12(m)(m)

Revenue vs. Earnings

USD

31 Mar 2018 ■ Revenue 417.37M ■ Earnings -17.50M — Profit margin -4.19%

-91.28M-8.0%112.30M-5.3%315.87M-2.6%519.45M0.0%31 Mar 2017: revenue 286.18M; earnings -2.75M; profit margin -0.96%31 Mar 201730 Jun 2017: revenue 288.35M; earnings -4.47M; profit margin -1.55%30 Jun 201731 Dec 2017: revenue 460.35M; earnings -32.18M; profit margin -6.99%31 Dec 201731 Mar 2018: revenue 417.37M; earnings -17.50M; profit margin -4.19%31 Mar 2018

31 Dec 2016 ■ Revenue 1.15B ■ Earnings 0.01B — Profit margin 0.83%

-0.21B-17.3%0.29B-11.0%0.79B-4.6%1.29B1.8%31 Dec 2013: revenue 0.28B; earnings -0.01B; profit margin -3.18%31 Dec 201331 Dec 2014: revenue 0.40B; earnings -0.07B; profit margin -16.34%31 Dec 201431 Dec 2015: revenue 0.96B; earnings 0.00B; profit margin 0.15%31 Dec 201531 Dec 2016: revenue 1.15B; earnings 0.01B; profit margin 0.83%31 Dec 2016

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$14.41(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$14.41High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning SGRY

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Mar 2018.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
16.00K
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
2.49M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-8.80%*
Total return · month
5.26%*
Total return · quarter
-12.98%*
Total return · half year
25.41%*
Total return · year to date
-6.73%*
Total return · 1 year
-34.23%*
Total return · 3 years
-50.74%*
Total return · 5 years
-65.97%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Surgery Partners, Inc. Overview

View more →

(m)

(m)

SEC CIK
1638833
Industry (SIC)
8062 Services-General Medical & Surgical Hospitals, NEC
Country of operation
United States
Business address
340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD, Tennessee, United States
Fiscal year end
1231
Phone
615-234-5900

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ardent Health, Inc. (ARDT)United States$1.478B17.91
COMMUNITY HEALTH SYSTEMS INC (CYH)United States$0.405B1.87
TENET HEALTHCARE CORP (THC)United States$20.097B
HCA Healthcare, Inc. (HCA)United States$93.934B15.49